Who
Mary Anne Heino
Executive Chair and CEO
Company insider
Files Form 4 as: Executive Chair and CEO, Lantheus Holdings.
In numbers
- Trades disclosed
- 130
- Buys
- 0
- Sells
- 45
- Bought
- $0
- Sold
- $44.9M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 25 Jun 2015
- Last trade
- 14 May 2026
- Last filed
- 3 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 14 May 2026filed 3 Jun 2026 | LNTH Lantheus HoldingsDiagnostics & Labs | SEC FORM 4 Code F | $119K1,227 at $96.67 | filing |
| 14 May 2026filed 3 Jun 2026 | LNTH Lantheus HoldingsDiagnostics & Labs | SEC FORM 4 Code F | $119K1,227 at $96.67 | filing |
| 2 Mar 2026filed 4 Mar 2026 | LNTH Lantheus HoldingsDiagnostics & Labs | SEC FORM 4 Code A | —32,105 at $0.00 | filing |
| 2 Mar 2026filed 4 Mar 2026 | LNTH Lantheus HoldingsDiagnostics & Labs | SEC FORM 4 Code F | $3.2M41,916 at $76.30 | filing |
| 2 Mar 2026filed 4 Mar 2026 | LNTH Lantheus HoldingsDiagnostics & Labs | SEC FORM 4 Code A | —32,105 at $0.00 | filing |
| 2 Mar 2026filed 4 Mar 2026 | LNTH Lantheus HoldingsDiagnostics & Labs | SEC FORM 4 Code F | $3.2M41,916 at $76.30 | filing |
| 17 Nov 2025filed 19 Nov 2025 | LNTH Lantheus Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —26,325 at $0.00 | filing |
| 17 Nov 2025filed 19 Nov 2025 | LNTH Lantheus HoldingsDiagnostics & Labs | SEC FORM 4 Code A | —14,285 at $0.00 | filing |
| 2 Jun 2025filed 4 Jun 2025 | LNTH Lantheus HoldingsDiagnostics & Labs | SEC FORM 4 Sold | $235K3,140 at $74.90 | filing |
| 2 Jun 2025filed 4 Jun 2025 | LNTH Lantheus HoldingsDiagnostics & Labs | SEC FORM 4 Sold | $1.8M22,926 at $77.09 | filing |
| 27 May 2025filed 29 May 2025 | LNTH Lantheus HoldingsDiagnostics & Labs | SEC FORM 4 Code G | —179,300 at $0.00 | filing |
| 27 May 2025filed 29 May 2025 | LNTH Lantheus HoldingsDiagnostics & Labs | SEC FORM 4 Code G | —179,300 at $0.00 | filing |
| 14 May 2025filed 16 May 2025 | LNTH Lantheus Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —4,543 at $0.00 | filing |
| 14 May 2025filed 16 May 2025 | LNTH Lantheus HoldingsDiagnostics & Labs | SEC FORM 4 Code A | —2,537 at $0.00 | filing |
| 13 Mar 2025filed 17 Mar 2025 | LNTH Lantheus HoldingsDiagnostics & Labs | SEC FORM 4 Sold | $2002 at $100.13 | filing |
| 13 Mar 2025filed 17 Mar 2025 | LNTH Lantheus HoldingsDiagnostics & Labs | SEC FORM 4 Code G | —8,618 at $0.00 | filing |
| 13 Mar 2025filed 17 Mar 2025 | LNTH Lantheus HoldingsDiagnostics & Labs | SEC FORM 4 Code G | —8,618 at $0.00 | filing |
| 3 Mar 2025filed 5 Mar 2025 | LNTH Lantheus HoldingsDiagnostics & Labs | SEC FORM 4 Code A | —50,070 at $0.00 | filing |
| 3 Mar 2025filed 5 Mar 2025 | LNTH Lantheus HoldingsDiagnostics & Labs | SEC FORM 4 Sold | $578K6,265 at $92.29 | filing |
| 3 Mar 2025filed 5 Mar 2025 | LNTH Lantheus HoldingsDiagnostics & Labs | SEC FORM 4 Sold | $855K9,160 at $93.32 | filing |
News
No headline names them, or the companies they trade most, lately.